CA2265198A1 - Method of producing a nicotine medicament and a medicament made by the method - Google Patents
Method of producing a nicotine medicament and a medicament made by the method Download PDFInfo
- Publication number
- CA2265198A1 CA2265198A1 CA002265198A CA2265198A CA2265198A1 CA 2265198 A1 CA2265198 A1 CA 2265198A1 CA 002265198 A CA002265198 A CA 002265198A CA 2265198 A CA2265198 A CA 2265198A CA 2265198 A1 CA2265198 A1 CA 2265198A1
- Authority
- CA
- Canada
- Prior art keywords
- nicotine
- medicament
- producing
- flowable mixture
- produce
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
Abstract
A method of producing a nicotine medicament for use in an inhaler comprises combining a nicotine formulation, a sugar and a liquid carrier including water to produce a flowable mixture and drying the flowable mixture at conditions to produce particles of the nicotine medicament suitable for delivery to the alveoli and lower airways of the person. Also disclosed is a nicotine medicament made by the method. The nicotine composition produced by this method is a composite particle suitable for tobacco replacement or withdrawal therapy.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002265198A CA2265198C (en) | 1998-03-11 | 1999-03-10 | Method of producing a nicotine medicament and a medicament made by the method |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002231968A CA2231968A1 (en) | 1998-03-11 | 1998-03-11 | Method of producing a nicotine medicament |
CA2,231,968 | 1998-03-11 | ||
CA002265198A CA2265198C (en) | 1998-03-11 | 1999-03-10 | Method of producing a nicotine medicament and a medicament made by the method |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2265198A1 true CA2265198A1 (en) | 1999-09-11 |
CA2265198C CA2265198C (en) | 2009-01-27 |
Family
ID=29712972
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002265198A Expired - Lifetime CA2265198C (en) | 1998-03-11 | 1999-03-10 | Method of producing a nicotine medicament and a medicament made by the method |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2265198C (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9585835B1 (en) | 2015-09-16 | 2017-03-07 | Sansa Corporation (Barbados) Inc. | Inhalable nicotine formulations and methods of making and using the same |
US9968125B2 (en) | 2015-01-09 | 2018-05-15 | Philip Morris Products S.A. | Nicotine—diketopiperazine microparticle formulations and methods of making the same |
US10149844B2 (en) | 2015-09-16 | 2018-12-11 | Philip Morris Products S.A. | Inhalable nicotine formulations, and methods of making and using thereof |
US11224594B2 (en) | 2015-09-16 | 2022-01-18 | Philip Morris Products S.A. | Nicotine formulations and methods of making and using the same |
US11707432B2 (en) | 2015-09-16 | 2023-07-25 | Philip Morris Products S.A. | System and method for controlling the harshness of nicotine-based dry powder formulations |
WO2023187393A1 (en) | 2022-03-31 | 2023-10-05 | Hovione Scientia Limited | Inhalation composite and carrier based formulation combination |
-
1999
- 1999-03-10 CA CA002265198A patent/CA2265198C/en not_active Expired - Lifetime
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9968125B2 (en) | 2015-01-09 | 2018-05-15 | Philip Morris Products S.A. | Nicotine—diketopiperazine microparticle formulations and methods of making the same |
US9585835B1 (en) | 2015-09-16 | 2017-03-07 | Sansa Corporation (Barbados) Inc. | Inhalable nicotine formulations and methods of making and using the same |
US10149844B2 (en) | 2015-09-16 | 2018-12-11 | Philip Morris Products S.A. | Inhalable nicotine formulations, and methods of making and using thereof |
US10660883B2 (en) | 2015-09-16 | 2020-05-26 | Philip Morris Products S.A. | Inhalable nicotine formulations, and methods of making and using thereof |
US11224594B2 (en) | 2015-09-16 | 2022-01-18 | Philip Morris Products S.A. | Nicotine formulations and methods of making and using the same |
US11707432B2 (en) | 2015-09-16 | 2023-07-25 | Philip Morris Products S.A. | System and method for controlling the harshness of nicotine-based dry powder formulations |
WO2023187393A1 (en) | 2022-03-31 | 2023-10-05 | Hovione Scientia Limited | Inhalation composite and carrier based formulation combination |
Also Published As
Publication number | Publication date |
---|---|
CA2265198C (en) | 2009-01-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1036940A1 (en) | Nicotine inhaler. | |
EP0831777B1 (en) | Dinucleotides useful for the treatment of lung disease | |
CA2146954A1 (en) | Breath activated nicotine inhalers | |
WO2002024158A8 (en) | Pulmonary delivery in treating disorders of the central nervous system | |
MY115688A (en) | Pharmaceutical composition for administration by inhalation | |
IS1768B (en) | Inhalant pharmaceutical composition containing insulin | |
HUP0102892A2 (en) | Drug delivery system comprising a tightly compacted solid medicament stock, process for its preparation and for its use | |
CA2277913A1 (en) | New formulation for inhalation having a poured bulk density of 0.28 to 0.38 g/ml, a process for preparing the formulation and the use thereof | |
EE04628B1 (en) | Powder with Perforated Microstructures and Method for Preparing a Microparticle Composition and Powder with Perforated Microstructures | |
CZ80395A3 (en) | Pharmaceutical preparation | |
US20120042886A1 (en) | Method of producing a nicotine medicament and a medicament made by the method | |
RU97102349A (en) | COMPOSITION FOR PRODUCING MEDICINE (OPTIONS) AND METHOD FOR PRODUCING IT | |
WO2004064811A1 (en) | A composition material for transmucosal delivery | |
CA2240717A1 (en) | Method of treating and diagnosing sleep disordered breathing and means for carrying out the method | |
JP2001527442A (en) | How to administer halotherapy | |
CA2265198A1 (en) | Method of producing a nicotine medicament and a medicament made by the method | |
CA2354576A1 (en) | Pharmaceutical preparation for inhalation of an opioid | |
EP0741588B1 (en) | Method to produce an aerosol | |
WO2001062264A3 (en) | Halotherapy method by inhalation of sodium chloride | |
CN1129088A (en) | Substitute for cigarette and using method thereof | |
JP2002161030A (en) | Method for inhaling mixed powder having different particle diameter | |
ZA200505872B (en) | A composition material for transmucosal delivery |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKEX | Expiry |
Effective date: 20190311 |